Beauvericin Ameliorates Experimental Colitis by Inhibiting Activated T Cells via Downregulation of the PI3K/Akt Signaling Pathway

Xuefeng Wu(Nanjing University), Yang Sun(Nanjing University)
PLoS ONE
December 10, 2013
Cited by 68


Related Papers